Ticker Scorecard - CORT Basics Company: Corcept Therapeutics Incorporated IPO Date: April 14, 2004 Sector: Healthcare Industry: Pharma Market Cap: $7.01B Activated in VL: True Average Daily Range Avg Daily Range: $0.24 | 2.79% Avg Daily Range (30 D): $1.46 | 2.56% Avg Daily Range (90 D): $1.21 | 2.29% Institutional Daily Volume Avg Daily Volume: .46M Avg Daily Volume (30 D): .63M Avg Daily Volume (90 D): .7M Trade Size Avg Trade Size (Sh.): 110 Avg Trade Size (Sh.) (30 D): 44 Avg Trade Size (Sh.) (90 D): 50 Institutional Trades Total Inst.Trades: 3,832 Avg Inst. Trade: $2.31M Avg Inst. Trade (30 D): $5.49M Avg Inst. Trade (90 D): $4.88M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.97M Avg Closing Trade (30 D): $10.46M Avg Closing Trade (90 D): $9.21M Avg Closing Volume: 135.86K     News Dec 11, 2024 @ 6:00 PM Alcohol Use Disorder Market Set for Remarkable Gro... Source: Delveinsight Sep 19, 2024 @ 7:36 PM Corcept Moves 6.5% Higher: Will This Strength Last... Source: Zacks Sep 3, 2024 @ 8:29 PM Corcept Shares Rise More Than 45% in Six Months: H... Source: Zacks Aug 6, 2024 @ 10:20 AM Should You Invest in the First Trust NYSE Arca Bio... Source: Zacks Investment Research Jun 26, 2024 @ 3:13 PM Corcept (CORT) Shares Rise 20% in Three Months: He... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $1.36 $.45 $.34 Diluted EPS $1.26 $.41 $.32 Revenue $ 628.56M $ 182.55M $ 163.8M Gross Profit $ 618.75M $ 179.68M $ 161.27M Net Income / Loss $ 141.82M $ 47.21M $ 35.49M Operating Income / Loss $ 143.36M $ 46.6M $ 35.59M Cost of Revenue $ 9.8M $ 2.87M $ 2.52M Net Cash Flow $ 25.49M $ 8.7M $ -21.16M PE Ratio 53.97